AI steps in to guide doctors in liver cancer battle
NCT ID NCT07157085
Summary
This study tested a new artificial intelligence (AI) tool designed to help doctors make better treatment decisions for patients with liver cancer (hepatocellular carcinoma). The AI analyzed patient data to predict how the disease might progress and how well different treatments like surgery or targeted therapy might work. The goal was to use this tool to create more personalized treatment plans for 7,000 participants, with the hope of helping them live longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Guangzhou, Guangdong, China
Conditions
Explore the condition pages connected to this study.